Aptinyx EV 2011-2026 | APTX

EV Jährlich Aptinyx

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-18.3 M	118 M	27.2 M	37.5 M	-37.3 M	44.4 M	27.2 M	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
118 M	-37.3 M	28.4 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Apellis Pharmaceuticals APLS	3.01 B	$ 20.7	-1.24 %	$ 2.61 B	USA
Aptorum Group Limited APM	9.45 M	$ 0.84	7.59 %	$ 4.58 M	China
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Axsome Therapeutics AXSM	8.95 B	$ 166.38	1.52 %	$ 8.28 B	USA
AbCellera Biologics ABCL	1.22 B	$ 3.82	5.82 %	$ 1.14 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
Burford Capital Limited BUR	3.22 B	$ 8.73	3.44 %	$ 1.37 B	Britain
Capricor Therapeutics CAPR	177 M	$ 26.86	-3.83 %	$ 719 M	USA
Codexis CDXS	354 M	$ 1.02	0.99 %	$ 74.9 M	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Cellectis S.A. CLLS	109 M	$ 3.8	-2.06 %	$ 116 M	France
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
CNS Pharmaceuticals CNSP	-3.42 M	$ 3.13	-0.95 %	$ 1.2 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Collegium Pharmaceutical COLL	2.52 B	$ 41.6	-0.17 %	$ 1.32 B	USA
Corcept Therapeutics Incorporated CORT	3.82 B	$ 35.97	0.76 %	$ 3.74 B	USA
Catalyst Pharmaceuticals CPRX	2.48 B	$ 23.88	3.47 %	$ 2.92 B	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Corbus Pharmaceuticals Holdings CRBP	66.5 M	$ 8.35	-2.57 %	$ 36.1 M	USA
Curis CRIS	40.5 M	$ 1.08	-5.26 %	$ 6.81 M	USA
Crinetics Pharmaceuticals CRNX	4.14 B	$ 40.68	-1.02 %	$ 3.83 B	USA
Corvus Pharmaceuticals CRVS	88.4 M	$ 17.89	-2.03 %	$ 859 M	USA
Champions Oncology CSBR	125 M	$ 6.07	2.71 %	$ 82.9 M	USA
Citius Pharmaceuticals CTXR	63.5 M	$ 0.72	-2.3 %	$ 4.84 M	USA
CEL-SCI Corporation CVM	35.5 M	$ 3.83	-10.09 %	$ 244 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Daré Bioscience DARE	37 M	$ 1.61	-5.29 %	$ 13.7 M	USA
DBV Technologies S.A. DBVT	636 M	$ 23.25	10.77 %	$ 2.26 B	France
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Precision BioSciences DTIL	74.1 M	$ 4.33	3.1 %	$ 16.6 M	USA
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	-75.9 M	$ 3.34	0.3 %	$ 1.2 M	USA
Dyadic International DYAI	43.9 M	$ 0.77	-1.68 %	$ 22.2 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Editas Medicine EDIT	242 M	$ 2.15	-2.27 %	$ 177 M	USA
Edesa Biotech EDSA	6.91 M	$ 2.28	3.64 %	$ 7.29 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	1.65 B	$ 29.2	-3.41 %	$ 1.69 B	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Equillium EQ	89.5 M	$ 1.92	5.49 %	$ 66.7 M	USA